Mortimer and Damian Marley take survey a sick society in the unsettling, but powerful, new video for their collaboration, 'In ...
TransMedics Group (NASDAQ: TMDX) has emerged as a medical devices industry leader, capturing strong growth and climbing ...
Some hearts are round, others more elongated, and as it turns out, these differences aren't just simple curiosities; they ...
Altria's stock is up by more than 30% over the past year, with a recent, and sizable, post-earnings jump. Is it worth this ...
Dr. Tom C. Nguyen describes what he eats on a typical day and explains how his diet helps him to avoid heart disease.
Analysing Cytokinetics' potential in the biopharma market with its drug aficamten, projected peak sales of $3.6 billion and ...
From the beginning of 2024 through Aug. 23, shares of TransMedics (NASDAQ: TMDX) stock soared by 123% -- but the good times ...
Thanks to an excellent investigation by The Times, we now know that in the 12 months up until June this year, police forces ...
Shares initiated a two year, 87% decline in value, accelerated by the bear market of 2022. Now, with positive revenue and ...
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...
We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...
Alembic Pharmaceuticals Limited announced today it has received final approval from the US Food & Drug Administration (USFDA) ...